Zanubrutinib
Obinutuzumab
Acalabrutinib
Update Venetoclax in CLL
ASCO: COVID-19 Medical Resources
Patient Power
JNCCN: How To Manage Cancer Care During COVID-19 Pandemic
JADPRO Roundtable Series: Best Practices in the Use of BTK Inhibitors in CLL